Arkolith/Insider Trading/ANGN/Form 4

Rhodes Jennifer J

See RemarksAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed Mar 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2022Grant(A)175K—$0175K
Mar 2, 2022Grant(A)100K—$0275K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601485-22-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML